Correction: FN3K expression in COPD: a potential comorbidity factor for cardiovascular disease

Correction: FN3K expression in COPD: a potential comorbidity factor for cardiovascular disease

Saved in:

Bibliographic Details
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2021-01-01
Series:	BMJ Open Respiratory Research
Online Access:	https://bmjopenrespres.bmj.com/content/8/1/e000714corr1.full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

FN3K expression in COPD: a potential comorbidity factor for cardiovascular disease
by: Irfan Rahman, et al.
Published: (2020-12-01)

COPD: THE IMPACT OF COMORBID CARDIOVASCULAR DISEASE ON THE LEVEL OF FRACTIONAL EXHALED NITRIC OXIDE
by: T.A. Pertseva, et al.
Published: (2017-03-01)

Fs = ?s Fn
by: Bruno Ministro, et al.
Published: (2016-09-01)

Thyroid Gland Disease as a Comorbid Condition in COPD
by: Aziz Gumus, et al.
Published: (2021-01-01)

FN:s kriminalpolitiske verksamhet
by: Inkeri Anttila
Published: (1983-08-01)

Effects of Shenyankang on expression of CTGF and FN in adriamycin-induced nephrosis rats
by: XIE Yi-feng, et al.
Published: (2019-01-01)

A simplified score to quantify comorbidity in COPD.
by: Nirupama Putcha, et al.
Published: (2014-01-01)

On Isomorphism Theorems of Fn -Polygroups
by: B. Davvaz
Published: (2013-09-01)

FN-konferansen som kultur
by: Thomas Mathiesen
Published: (1986-04-01)

PELABELAN P_2⊳F_n AJAIB SUPER DARI GRAF S_m⊳F_n
by: Ganesha Lapenangga Putra, et al.
Published: (2021-08-01)

TWEAK/Fn14 signaling in tumors
by: Guanglei Hu, et al.
Published: (2017-06-01)

Successful Smoking Cessation in COPD: Association with Comorbidities and Mortality
by: H. Kupiainen, et al.
Published: (2012-01-01)

Systemic inflammation and complications of”vascular" comorbidity in patients with COPD
by: A. S. Skotnikov, et al.
Published: (2015-10-01)

Prevalence of Bronchial Asthma and COPD in Comorbidity with COVID-19
by: P. G. Svist, et al.
Published: (2024-03-01)

FN1 from cancer-associated fibroblasts orchestrates pancreatic cancer metastasis via integrin-PI3K/AKT signaling
by: Xianguang Zhu, et al.
Published: (2025-07-01)

Biological pathways and mechanisms linking COPD and cardiovascular disease
by: Beatrice Ragnoli, et al.
Published: (2025-03-01)

Cardiovascular diseases and primary breast cancer: comorbidity and modified risk factors
by: I. V. Druk, et al.
Published: (2021-06-01)

The Components of Cepheid Systems: The FN Vel System
by: Nancy Remage Evans, et al.
Published: (2024-01-01)

FN-krönika: Förenta nationerna och kriminalpolitiken
by: Matti Joutsen
Published: (1997-11-01)

Evaluation of cardiovascular comorbidity in cancer patients and analysis of potential risk factors for cardiovascular complications of checkpoint inhibitor therapy
by: E. A. Kushnareva, et al.
Published: (2022-01-01)

Comorbidity in chronic obstructive pulmonary disease and cardiovascular disease
by: A. M. Chaulin, et al.
Published: (2021-05-01)

Targets for the prevention of comorbidity of cardiovascular and cancer diseases
by: M. N. Mamedov, et al.
Published: (2022-12-01)

TWEAK/Fn14 Activation Participates in Skin Inflammation
by: Qilu Liu, et al.
Published: (2017-01-01)

Comorbidities reduce survival and quality of life in COPD with severe lung hyperinflation
by: Else A.M.D. ter Haar, et al.
Published: (2024-11-01)

Clinical presentation and comorbidities of obstructive sleep apnea-COPD overlap syndrome.
by: Dan Adler, et al.
Published: (2020-01-01)

Identification of key molecular targets for stachyose in hepatocellular carcinoma: focus on STAT3 and FN1
by: Haihua Chen, et al.
Published: (2025-07-01)

COMORBID PATIENT IN THE INTERNAL MEDICINE: CARDIOVASCULAR DISEASES AND ANXIETY
by: G. B. Selivanova
Published: (2017-10-01)

Establishment of an alternative splicing prognostic risk model and identification of FN1 as a potential biomarker in glioblastoma multiforme
by: Xi Liu, et al.
Published: (2025-02-01)

Targeting PRDX2 to inhibit tumor growth and metastasis in triple-negative breast cancer: the role of FN1 and the PI3K/AKT/SP1 pathway
by: Jiawei Zhou, et al.
Published: (2025-04-01)

Obstructive sleep apnea and cardiovascular comorbidity: common pathophysiological mechanisms to cardiovascular disease
by: M. V. Agaltsov, et al.
Published: (2021-09-01)

COTE and Pulmonary Comorbidities Predict Moderate-to-Severe Acute Exacerbation and Hospitalization in COPD
by: Chen Q, et al.
Published: (2025-06-01)

Lung Function Decline in COPD – Relations to Changes in Symptom Burden, Inflammation, and Comorbidities
by: Juan Wang, et al.
Published: (2025-07-01)

Comorbidity-driven COPD outcomes: the urgent need for full optimisation by respiratory physicians
by: Sobia Chaudhary, et al.
Published: (2025-07-01)

Breathing exercises with PEEP: efficiency and duration for correcting the cardiovascular system functional state in older patients with COPD
by: E. O. Asanov, et al.
Published: (2021-11-01)

Comorbid Influences on Generic Health-Related Quality of Life in COPD: A Systematic Review.
by: Manuel B Huber, et al.
Published: (2015-01-01)

MIP-T3 Expression Associated with Defects of Ciliogenesis in Airway of COPD Patients
by: Wen-Jun Wang, et al.
Published: (2020-01-01)

Integrated multi-omics analysis reveals the immunotherapeutic significance of tumor cells with high FN1 expression in ovarian cancer
by: Xinyi Zhang, et al.
Published: (2025-06-01)

Hypersensitive pneumonitis and cardiovascular comorbidity
by: A. V. Medvedev, et al.
Published: (2025-06-01)

Rheumatoid arthritis and cardiovascular comorbidities
by: Uğur Özkan, et al.
Published: (2023-12-01)

Association of cardiovascular health with COPD (NHANES 2007-2020): mediating potential of lean body mass
by: Ruoyu Gou, et al.
Published: (2025-04-01)